Exclusive Interview with Arcellx, Inc. and Creighton University: A Collaborative Approach to Advancing Cancer Treatments
NEW YORK, March 18, 2025 — Today’s Marketplace (TMP) is thrilled to present an enlightening conversation between Arcellx, Inc. (ACLX) Chief Medical Officer, Christopher Heery, M.D., and Jessica Clark, DNP, RN, Dean of the College of Nursing at Creighton University. This collaboration between a leading biotech company and a renowned educational institution is paving the way for innovative cancer treatments and research.
Arcellx, Inc.: Pioneering CAR-T Cell Therapy
Christopher Heery: Arcellx is dedicated to transforming the lives of patients with hematologic malignancies through our CAR-T cell therapy, CARVYX. Our proprietary Pince technology allows us to produce a functional, allogeneic CAR-T cell therapy at scale, making it more accessible and affordable for a greater number of patients.
Creighton University: Committed to Nursing Education and Research
Jessica Clark: Creighton University’s College of Nursing is committed to advancing nursing education and research, with a focus on patient-centered care. Our partnership with Arcellx is a perfect example of how we are integrating real-world applications into our curriculum and preparing nurses to be at the forefront of innovative healthcare solutions.
Collaborative Research and Clinical Trials
Christopher Heery: Our partnership with Creighton University allows us to collaborate on research projects and clinical trials, ensuring that our CAR-T cell therapy is safe, effective, and accessible to a diverse patient population. We’re also providing nursing students with valuable hands-on experience, preparing them for careers in oncology and other specialized fields.
Impact on Patients and the World
The collaboration between Arcellx and Creighton University is a game-changer for the field of oncology. This partnership:
- Brings affordable, scalable CAR-T cell therapy to more patients, improving their quality of life and potentially extending their lifespan.
- Provides nursing students with invaluable real-world experience and knowledge, preparing them to be leaders in oncology care and research.
- Advances the scientific community’s understanding of CAR-T cell therapy and its applications, opening doors for new discoveries and treatments.
Conclusion
The collaboration between Arcellx, Inc. and Creighton University is a powerful example of how industry and academia can work together to drive innovation and make a difference in the lives of patients. As this partnership continues to grow, we can expect groundbreaking advancements in cancer treatments and nursing education, ultimately improving healthcare for individuals and communities around the world.
Stay tuned to Today’s Marketplace for more updates on this exciting partnership and the latest developments in the world of healthcare and biotechnology.
# # #
